ClinicalTrials.gg
CompletedNCT04755790Updated Jan 24, 2024Results posted

To Assess the Utility of the Point Digit in a Clinical Take-home Study

An interventional study of Point Digit in Amputation; Traumatic, Hand, sponsored by Point Designs. Completed at 7 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-24.

Sponsored by Point Designs · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 months after the study started (first participant enrolled May 2020, registered Nov 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will allow us to assess whether the Point Digit confers functional and psychological benefit to persons with partial hand amputations in an unconstrained environment. The use of the Point Digit outside of the laboratory will allow for a wider variety of uses and for a more realistic simulation of the product being used in the field. This well-controlled trial (without randomization of subjects) will produce the first Level II-1 medical evidence in our field of partial hand prosthetic design as described by the 1989 U.S. Preventive Services Task Force. Furthermore, this study will provide important data to support providers who are requesting reimbursement from payers.

02

Conditions studied

  • Amputation; Traumatic, Hand

Browse trials for

03

In context

Amputation, Traumatic

112 studies on the registry are indexed under Amputation, Traumatic; 24 are open to participants now.

This study's enrollment of 13 is below the median of 15 across 75 interventional studies indexed under Amputation, Traumatic.

Browse Amputation, Traumatic studies →

Lead sponsor

Point Designs is the lead sponsor of 8 studies on the registry; 2 are open to participants now.

Of its 5 completed or terminated interventional studies of FDA-regulated products, 5 (100%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Partial hand amputees with absence of index and/or middle fingers and presence of thumb. Additional finger loss is acceptable if all other criterion are met.
  • Fluent in English
  • Individuals aged 18 or greater

Exclusion criteria

Exclusion Criteria:

  • Significant cognitive deficits as determined upon clinical evaluation
  • Significant neurological deficits as determined upon clinical evaluation
  • Significant physical deficits of the residual limb impacting full participation in the study as determined upon clinical evaluation
  • Uncontrolled pain or phantom pain impacting full participation in the study as determined upon occupational therapist evaluation
  • Serious uncontrolled medical problems as judged by the project therapist.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • No intervention
    No Prosthesis

    Baseline outcome measurements will be performed without a prosthesis

  • Experimental
    Prosthesis

    Outcome measurements will be performed after the subject has been fit with a prosthesis at 3 different points in time: immediately post-fitting, \~30 days post-fitting, and \~60 days post-fitting

    Device: Point Digit

Interventions

  • DevicePoint Digit

    Patient is fit with Point Digit partial hand prosthetic system

06

What researchers measure

Primary outcomes

  1. Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

    Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: Day 0: no prosthesis (pre-fitting)

  2. Disability of the Arm, Shoulder and Hand (DASH)

    The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

    Time frame: Day 0: no prosthesis (pre-fitting)

  3. Southampton Hand Assessment Procedure (SHAP)

    The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: Day 0: no prosthesis (pre-fitting)

  4. EuroQol-5 Dimension (EQ-5D-5L)

    Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: Day 0: no prosthesis (pre-fitting)

  5. Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

    Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: Day 0: with prosthesis, immediately post-fitting

  6. Disability of the Arm, Shoulder and Hand (DASH)

    The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

    Time frame: Day 0: with prosthesis, immediately post-fitting

  7. Southampton Hand Assessment Procedure (SHAP)

    The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: Day 0: with prosthesis, immediately post-fitting

  8. EuroQol-5 Dimension (EQ-5D-5L)

    Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: Day 0: with prosthesis, immediately post-fitting

  9. Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

    Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: ~Day 30: with prosthesis, 30 days post-fitting

  10. Disability of the Arm, Shoulder and Hand (DASH)

    The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

    Time frame: ~Day 30: with prosthesis, 30 days post-fitting

  11. Southampton Hand Assessment Procedure (SHAP)

    The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: ~Day 30: with prosthesis, 30 days post-fitting

  12. EuroQol-5 Dimension (EQ-5D-5L)

    Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: ~Day 30: with prosthesis, 30 days post-fitting

  13. Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

    Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: ~Day 60: with prosthesis, 60 days post-fitting

  14. Disability of the Arm, Shoulder and Hand (DASH)

    The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

    Time frame: ~Day 60: with prosthesis, 60 days post-fitting

  15. Southampton Hand Assessment Procedure (SHAP)

    The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: ~Day 60: with prosthesis, 60 days post-fitting

  16. EuroQol-5 Dimension (EQ-5D-5L)

    Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

    Time frame: ~Day 60: with prosthesis, 60 days post-fitting

07

Results

Posted Jan 24, 2024

Participant flow

No Prosthesis (Day 0)
Participant flow — No Prosthesis (Day 0)
MilestoneNo Prosthesis, Then Prosthesis
Started13
Completed13
Not completed0
Prosthesis (Day 0)
Participant flow — Prosthesis (Day 0)
MilestoneNo Prosthesis, Then Prosthesis
Started13
Completed13
Not completed0
Prosthesis (Day 30)
Participant flow — Prosthesis (Day 30)
MilestoneNo Prosthesis, Then Prosthesis
Started13
Completed11
Not completed2
Prosthesis (Day 60)
Participant flow — Prosthesis (Day 60)
MilestoneNo Prosthesis, Then Prosthesis
Started11
Completed11
Not completed0

Outcome measures

PrimaryCapacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
Day 0: no prosthesis (pre-fitting)
Reported as:
Mean · scores on a scale
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
scores on a scaleNo Prosthesis, Then Prosthesis
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)74.6 ± 34.0
PrimaryDisability of the Arm, Shoulder and Hand (DASH)

The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

Time frame:
Day 0: no prosthesis (pre-fitting)
Reported as:
Mean · score on a scale
Disability of the Arm, Shoulder and Hand (DASH)
score on a scaleNo Prosthesis, Then Prosthesis
Disability of the Arm, Shoulder and Hand (DASH)29.8 ± 14.6
PrimarySouthampton Hand Assessment Procedure (SHAP)

The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
Day 0: no prosthesis (pre-fitting)
Reported as:
Mean · score on a scale
Southampton Hand Assessment Procedure (SHAP)
score on a scaleNo Prosthesis, Then Prosthesis
Southampton Hand Assessment Procedure (SHAP)70.9 ± 29.5
PrimaryEuroQol-5 Dimension (EQ-5D-5L)

Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
Day 0: no prosthesis (pre-fitting)
Reported as:
Mean · score on a scale
EuroQol-5 Dimension (EQ-5D-5L)
score on a scaleNo Prosthesis, Then Prosthesis
EuroQol-5 Dimension (EQ-5D-5L)84.5 ± 12.5
PrimaryCapacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
Day 0: with prosthesis, immediately post-fitting
Reported as:
Mean · scores on a scale
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
scores on a scaleNo Prosthesis, Then Prosthesis
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)84.0 ± 13.1
PrimaryDisability of the Arm, Shoulder and Hand (DASH)

The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

Time frame:
Day 0: with prosthesis, immediately post-fitting
Reported as:
Mean · score on a scale
Disability of the Arm, Shoulder and Hand (DASH)
score on a scaleNo Prosthesis, Then Prosthesis
Disability of the Arm, Shoulder and Hand (DASH)21.4 ± 12.8
PrimarySouthampton Hand Assessment Procedure (SHAP)

The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
Day 0: with prosthesis, immediately post-fitting
Reported as:
Mean · score on a scale
Southampton Hand Assessment Procedure (SHAP)
score on a scaleNo Prosthesis, Then Prosthesis
Southampton Hand Assessment Procedure (SHAP)69.9 ± 20.7
PrimaryEuroQol-5 Dimension (EQ-5D-5L)

Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
Day 0: with prosthesis, immediately post-fitting
Reported as:
Mean · score on a scale
EuroQol-5 Dimension (EQ-5D-5L)
score on a scaleNo Prosthesis, Then Prosthesis
EuroQol-5 Dimension (EQ-5D-5L)88.5 ± 9.8
PrimaryCapacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
~Day 30: with prosthesis, 30 days post-fitting
Reported as:
Mean · scores on a scale
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
scores on a scaleNo Prosthesis, Then Prosthesis
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)86.8 ± 10.6
PrimaryDisability of the Arm, Shoulder and Hand (DASH)

The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

Time frame:
~Day 30: with prosthesis, 30 days post-fitting
Reported as:
Mean · score on a scale
Disability of the Arm, Shoulder and Hand (DASH)
score on a scaleNo Prosthesis, Then Prosthesis
Disability of the Arm, Shoulder and Hand (DASH)16.0 ± 9.9
PrimarySouthampton Hand Assessment Procedure (SHAP)

The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
~Day 30: with prosthesis, 30 days post-fitting
Reported as:
Mean · score on a scale
Southampton Hand Assessment Procedure (SHAP)
score on a scaleNo Prosthesis, Then Prosthesis
Southampton Hand Assessment Procedure (SHAP)74.9 ± 23.3
PrimaryEuroQol-5 Dimension (EQ-5D-5L)

Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
~Day 30: with prosthesis, 30 days post-fitting
Reported as:
Mean · score on a scale
EuroQol-5 Dimension (EQ-5D-5L)
score on a scaleNo Prosthesis, Then Prosthesis
EuroQol-5 Dimension (EQ-5D-5L)89.2 ± 8.5
PrimaryCapacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)

Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL) provides a comprehensive, performance based measure for upper limb prosthetic use with any upper-limb functional prosthesis at any amputation level through assessment of commonplace activities that take place in various planes of movement. Scale Title: Overall Performance. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
~Day 60: with prosthesis, 60 days post-fitting
Reported as:
Mean · scores on a scale
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)
scores on a scaleNo Prosthesis, Then Prosthesis
Capacity Assessment of Prosthetic Performance for the Upper Limb (CAPPFUL)91.0 ± 8.1
PrimaryDisability of the Arm, Shoulder and Hand (DASH)

The Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire is a 30-item questionnaire that looks at the ability of a patient to perform certain upper extremity activities. This questionnaire is a self-report questionnaire that patients can rate difficulty and interference with daily life on a 5 point Likert scale. Scale Title: DASH Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates worse outcome.

Time frame:
~Day 60: with prosthesis, 60 days post-fitting
Reported as:
Mean · score on a scale
Disability of the Arm, Shoulder and Hand (DASH)
score on a scaleNo Prosthesis, Then Prosthesis
Disability of the Arm, Shoulder and Hand (DASH)15.5 ± 10.5
PrimarySouthampton Hand Assessment Procedure (SHAP)

The Southampton Hand Assessment Procedure (SHAP) is a clinically validated hand function test. Originally developed to assess the effectiveness of upper limb prostheses, the SHAP has now been applied to assessment of musculoskeletal and neurological conditions. Scale Title: Index of Function. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
~Day 60: with prosthesis, 60 days post-fitting
Reported as:
Mean · score on a scale
Southampton Hand Assessment Procedure (SHAP)
score on a scaleNo Prosthesis, Then Prosthesis
Southampton Hand Assessment Procedure (SHAP)75.3 ± 21.2
PrimaryEuroQol-5 Dimension (EQ-5D-5L)

Descriptive system for health-related quality of life states in adults, consisting of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension. Scale Title: EQ-5D-5L Score. Scale Minimum: 0. Scale Maximum: 100. Higher score indicates better outcome.

Time frame:
~Day 60: with prosthesis, 60 days post-fitting
Reported as:
Mean · score on a scale
EuroQol-5 Dimension (EQ-5D-5L)
score on a scaleNo Prosthesis, Then Prosthesis
EuroQol-5 Dimension (EQ-5D-5L)90.1 ± 8.7

Adverse events

Collected over 1 year. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
No Prosthesis, Then Prosthesis0/11 (0%)0/11 (0%)0/11 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)All Participants
<=18 years0
Between 18 and 65 years13
>=65 years0
Sex: Female, Male
Sex: Female, Male(Participants)All Participants
Female3
Male10
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)All Participants
Hispanic or Latino3
Not Hispanic or Latino9
Unknown or Not Reported1
Race (NIH/OMB)
Race (NIH/OMB)(Participants)All Participants
American Indian or Alaska Native0
Asian1
Native Hawaiian or Other Pacific Islander0
Black or African American0
White8
More than one race1
Unknown or Not Reported3
08

Study locations

7 sites
  • Point Designs
    Lafayette, Colorado 80026, United States
  • Arm Dynamics
    Overland Park, Kansas 66209, United States
  • Arm Dynamics
    Maple Grove, Minnesota 55369, United States
  • Arm Dynamics
    Portland, Oregon 97223, United States
  • Arm Dynamics
    Philadelphia, Pennsylvania 19146, United States
  • Arm Dynamics
    Houston, Texas 77004, United States
  • Arm Dynamics
    Irving, Texas 75062, United States
09

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT04755790
Lead sponsor
Point Designs
Collaborators
University of Colorado, Denver, Arm Dynamics
Responsible party
Sponsor
First posted
Feb 16, 2021
Start date
May 18, 2020
Primary completion
Dec 31, 2022
Completion
Dec 31, 2022
Results posted
Jan 24, 2024
Last update
Jan 24, 2024

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion